Share to Facebook Share to Twitter More...

Experts To Review Sinovac Use For Kids, Adolescents

SINOVAC FOR KIDS – With a large supply of Sinovac Vaccines in the Philippines, health experts review its use on children.

According to members of the Vaccine Expert Panel (VEP), young children and adolescents are still susceptible to COVID-19. As such, a clinical trial review of its use on Children ages 3 to 17 is underway.

However, Dr. Edsel Salvana of the Technical Advisory Group said covering the use of vaccine for children could not be “automatic”. Still, Salvana said the data from China was still good news.

Sinovac Use For Kids – Medical Experts Review Possibility
Image from: SCMP

Furthermore, he emphasized that this vaccine could help speed up reopening face-to-face classes in the country. Similarly, the Food and Drug Administration (FDA) already amended the EUA for Pfizer for children 12 to 15 years old.

But, according to Inquirer, the agency had yet to make the decision public. Meanwhile, Eric Domingo said the FDA got a “favorable” results of evaluation conducted by the VEP for Pfizer.

Additionally, Dr. Rontgene Solante highlighted that children are just as vulnerable to the virus as adults. As per the article, Solante said:

Children are as vulnerable [to COVID] as adults. There are already reports in other countries with increasing cases [among] children, that’s why the approval of Pfizer was also fast-tracked for this age group, especially in the United States and Europe

What do you think about this? Should children be given vaccines against COVID-19? Leave your comments below.

Thanks for reading. We aim to provide our readers with the freshest and most in-demand content. Come back next time for the latest news here on Philnews.

READ ALSO: Leni Robredo’s Spokesman Speaks on Announcement of VP’s Plan for 2022 Elections

Share to Facebook Share to Twitter More...

comment(s) for this post "Sinovac Use For Kids – Medical Experts Review Possibility". Tell us what you think abut this post by leaving your comments below.